Bank of Montreal
BVS icon

Bank of Montreal’s Bioventus BVS Stock Holding History

Bank of Montreal’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-133,641
Closed -$774K – 3884
2024
Q2 		$774K Buy
+133,641
New +$733K ﹤0.01% 2167
2021
Q2 		– Sell
-291
Closed -$4K – 3830
2021
Q1 		$4K Buy
+291
New +$4.14K ﹤0.01% 4701

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal's BVS Position: Q3 2024 in Review

Bank of Montreal sold out of Bioventus (BVS) in Q3 2024, closing a stake of 133,641 shares — an estimated $774K sold.

Bank of Montreal first reported a position in BVS in Q1 2021 and held it in 2 quarters. The position peaked at $774K in Q2 2024. 138 funds tracked by Wall St. Rank hold BVS as of Q3 2024.

  • Bank of Montreal reported no remaining Bioventus position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 133,641 Bioventus shares in Q3 2024, an estimated $774K.
  • Bank of Montreal first reported a position in Bioventus in Q1 2021 and held it in 2 quarters.
  • Bank of Montreal's Bioventus position peaked at $774K in Q2 2024.
  • 138 funds tracked by Wall St. Rank held Bioventus as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.